Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.6519
-0.0181 (-2.70%)
Mar 31, 2025, 1:17 PM EDT - Market open
Biodesix Revenue
In the year 2024, Biodesix had annual revenue of $71.32M with 45.30% growth. Biodesix had revenue of $20.43M in the quarter ending December 31, 2024, with 39.28% growth.
Revenue (ttm)
$71.32M
Revenue Growth
+45.30%
P/S Ratio
1.22
Revenue / Employee
$261,256
Employees
273
Market Cap
95.16M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
BDSX News
- 27 days ago - Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewsWire
- 4 weeks ago - Biodesix to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewsWire
- 2 months ago - Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) - GlobeNewsWire
- 2 months ago - Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study - GlobeNewsWire
- 5 months ago - Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Biodesix Announces Third Quarter 2024 Results and Highlights - GlobeNewsWire